Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients ...

Insulin pumps and CGMS provide greater flexibility, improved blood sugar control, and better quality of life for children and ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

Soliqua 100/33 (insulin glargine/lixisenatide) is a prescription drug that’s used to treat type 2 diabetes. Soliqua 100/33 comes as a prefilled single-use pen for injecting the drug under your skin.

Type 1 diabetes (T1D) is an autoimmune condition where the body cannot produce insulin properly, and this can affect the life ...

Beta Bionics’ IPO marks one of the largest public offerings for an Orange County-based company in over three years, second ...

Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...

MORE than half of adults living with type 1 diabetes believe the condition stops them from being more spontaneous. A poll of ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...

A total of 70% of patients surveyed said they took insulin using a syringe and 30% said they used a pen; most (56%) changed their needle with each injection. Patients reported taking an average of ...